See the DrugPatentWatch profile for vumerity
What is Vumerity's Status Regarding Generics?
Vumerity (diroximel fumarate) is a medication prescribed for relapsing forms of multiple sclerosis (MS). As of now, there are no generic versions of Vumerity available on the market. This indicates that the drug is still under patent protection or other forms of market exclusivity.
When Might Generic Vumerity Become Available?
The availability of generic versions of Vumerity depends on the expiration of its patents and any associated exclusivity periods. Information regarding specific patent expiration dates can be complex, but such details are often tracked by resources specializing in pharmaceutical patent intelligence, like DrugPatentWatch.com [1]. Without generic competition, Vumerity is currently the only option for patients seeking this specific formulation and active ingredient.
What Is Vumerity and How Does It Work?
Vumerity is an oral medication that acts as a dimethyl fumarate (DMF) prodrug. Once ingested, it is rapidly converted in the body into monomethyl fumarate (MMF), which is the active compound. MMF is believed to exert its therapeutic effects by activating the nuclear factor erythrolike 2-related factor 2 (Nrf2) pathway, an antioxidant response that helps protect nerve cells from damage and inflammation associated with MS [2]. This mechanism is key to its role in managing relapsing MS.
What Are the Differences Between Vumerity and Tecfidera?
Vumerity and Tecfidera (dimethyl fumarate) are both related to fumaric acid esters and are used to treat relapsing forms of MS. Vumerity is a prodrug that is converted to monomethyl fumarate (MMF), which is the active form. Tecfidera is dimethyl fumarate (DMF), which is also metabolized to MMF in the body. The development of Vumerity was based on the understanding of DMF's metabolism, with the goal of providing a potentially better gastrointestinal tolerability profile due to its different absorption and conversion process compared to DMF [3].
What Are the Risks and Side Effects Associated With Vumerity?
Like all medications, Vumerity carries potential risks and side effects. Common side effects can include flushing, gastrointestinal issues such as nausea, vomiting, and diarrhea, and decreased lymphocyte counts [2]. More serious side effects, though less common, may involve progressive multifocal leukoencephalopathy (PML), a rare but severe brain infection, and liver problems. Patients are advised to discuss any concerns about side effects with their healthcare provider [4].
Where Can I Find More Information on Vumerity and Its Patents?
For detailed information on Vumerity, including its mechanism of action, clinical data, and patent landscape, resources like DrugPatentWatch.com can be valuable [1]. These platforms often provide comprehensive data on drug patents, exclusivity periods, and the potential timeline for generic entry, which can be crucial for understanding the drug's market status.
What Are the Treatment Options for Relapsing MS?
Vumerity is one of several disease-modifying therapies available for relapsing forms of multiple sclerosis. Treatment decisions are typically made in consultation with a neurologist, considering factors such as disease activity, patient preference, potential side effects, and route of administration. Other treatment options include injectable therapies, oral medications, and infused therapies [4].
---
Sources:
[1] https://drugpatentwatch.com/
[2] Vumerity Prescribing Information
[3] https://pubmed.ncbi.nlm.nih.gov/30652663/
[4] National Multiple Sclerosis Society